{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:46:21Z","timestamp":1785577581112,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jhepr.2021.100234","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T18:55:30Z","timestamp":1611255330000},"page":"100234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["European \u2018NAFLD Preparedness Index\u2019 \u2014 Is Europe ready to meet the challenge of fatty liver disease?"],"prefix":"10.1016","volume":"3","author":[{"given":"Jeffrey V.","family":"Lazarus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Palayew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Ekstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Marchesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Ratziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Zelber-Sagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cortez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin M.","family":"Anstee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100234_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11901-017-0378-2","article-title":"Natural history of NAFLD\/NASH","volume":"16","author":"Ekstedt","year":"2017","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.jhepr.2021.100234_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100234_bib5","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of nonalcoholic fatty liver disease","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100234_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2017.10693","article-title":"Global obesity epidemic worsening","volume":"318","author":"Friedrich","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2021.100234_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40842-016-0039-3","article-title":"Diabetes and its drivers: the largest epidemic in human history?","volume":"3","author":"Zimmet","year":"2017","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1016\/j.jhepr.2021.100234_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000492115","article-title":"Forecasting future trends in obesity across Europe: the value of improving surveillance","volume":"11","author":"Pineda","year":"2018","journal-title":"Obes Facts"},{"key":"10.1016\/j.jhepr.2021.100234_bib9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100234_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100234_bib11","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100234_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib13","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2021.100234_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100234_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12916-018-1149-9","article-title":"Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?","volume":"16","author":"Sanyal","year":"2018","journal-title":"BMC Med"},{"issue":"S1","key":"10.1016\/j.jhepr.2021.100234_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: what we need in the future","volume":"38","author":"Ara\u00fajo","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2021.100234_bib18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2021.100234_bib19","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100234_bib20","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2021.100234_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S000711451800137X","article-title":"Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial","volume":"120","author":"Katsagoni","year":"2018","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jhepr.2021.100234_bib23","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00464-017-5846-9","article-title":"How bariatric surgery affects liver volume and fat density in NAFLD patients","volume":"32","author":"Luo","year":"2018","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jhepr.2021.100234_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhep.2019.08.027","article-title":"A\u00a0cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe","volume":"72","author":"Lazarus","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib25","series-title":"Together on the road to universal health coverage: a call to action","year":"2017"},{"key":"10.1016\/j.jhepr.2021.100234_bib26","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/S0140-6736(18)32281-5","article-title":"Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2021.100234_bib27","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib29","series-title":"Encyclopedia of Measurement and Statistics","article-title":"Multiple correspondence analysis","author":"Abdi","year":"2007"},{"key":"10.1016\/j.jhepr.2021.100234_bib30","series-title":"Multiple correspondence analysis and related methods","author":"Greenacre","year":"2006"},{"key":"10.1016\/j.jhepr.2021.100234_bib31","series-title":"NICE Guideline \u2018Non-alcoholic Fatty Liver Disease (NAFLD): Assessment and Management\u2019","year":"2016"},{"key":"10.1016\/j.jhepr.2021.100234_bib32","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.jhepr.2020.100142","article-title":"Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study","volume":"2","author":"O'Hara","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2021.100234_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.21037\/hbsn.2020.03.03","article-title":"The socioeconomic aspects of nonalcoholic fatty liver disease: food insecurity as a novel risk factor for steatosis and liver fibrosis","volume":"9","author":"Frohme","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jhepr.2021.100234_bib34","series-title":"Tackling Obesities: Future Choices \u2013 Project Report","author":"Butland","year":"2007"},{"key":"10.1016\/j.jhepr.2021.100234_bib35","series-title":"Report of the Commission on Ending Childhood Obesity","year":"2017"},{"key":"10.1016\/j.jhepr.2021.100234_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020574","article-title":"Consumption of ultra-processed foods and associated sociodemographic factors in the USA between 2007 and 2012: evidence from a nationally representative cross-sectional study","volume":"8","author":"Baraldi","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2021.100234_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000507840","article-title":"Ultra-processed food consumption among the paediatric population: an overview and call to action from the European Childhood Obesity Group","volume":"76","author":"Khandpur","year":"2020","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.jhepr.2021.100234_bib38","first-page":"91","article-title":"Food insecurity may be an independent risk factor associated with nonalcoholic fatty liver disease among low-income adults in the United States","volume":"150","author":"Golovaty","year":"2020","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jhepr.2021.100234_bib39","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib40","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamainternmed.2019.2248","article-title":"Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"179","author":"Koutoukidis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jhepr.2021.100234_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100234_bib42","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100234_bib43","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/oby.21868","article-title":"Diet quality in midadulthood predicts visceral adiposity and liver fatness in older ages: the Multiethnic Cohort Study","volume":"25","author":"Maskarinec","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jhepr.2021.100234_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/j.gastro.2018.03.038","article-title":"Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease","volume":"155","author":"Ma","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100234_bib45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCULATIONAHA.117.030501","article-title":"Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial","volume":"137","author":"Gepner","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jhepr.2021.100234_bib46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","article-title":"ESPEN guideline on clinical nutrition in liver disease","volume":"38","author":"Plauth","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jhepr.2021.100234_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/liv.14669","article-title":"Prognostic accuracy of FIB-4, NAFLD fibrosis score, and APRI for NAFLD-related events: a systematic review","volume":"41","author":"Lee","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2021.100234_bib48","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100234_bib49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/imj.13667","article-title":"Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis","volume":"48","author":"Patel","year":"2018","journal-title":"Intern Med J"},{"key":"10.1016\/j.jhepr.2021.100234_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2468-1253(18)30077-3","article-title":"Non-alcoholic fatty liver disease and the interface between primary and secondary care","volume":"3","author":"Tsochatzis","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3399\/bjgp17X690557","article-title":"Detecting liver disease in primary care: are we ready for change?","volume":"67","author":"Jarvis","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jhepr.2021.100234_bib52","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/tbm\/ibz080","article-title":"Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study","volume":"10","author":"Hallsworth","year":"2020","journal-title":"Transl Behav Med"},{"key":"10.1016\/j.jhepr.2021.100234_bib53","series-title":"Human Development Report","year":"2019"},{"key":"10.1016\/j.jhepr.2021.100234_bib54","doi-asserted-by":"crossref","first-page":"P948","DOI":"10.1016\/S2468-1253(20)30011-X","article-title":"Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?","volume":"5","author":"Palayew","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100234_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235715","article-title":"The Hep-CORE policy score: a European hepatitis C national policy implementation ranking based on patient organization data","volume":"15","author":"Palayew","year":"2020","journal-title":"PLoS One"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:25:58Z","timestamp":1762899958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2589555921000100"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100234","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European \u2018NAFLD Preparedness Index\u2019 \u2014 Is Europe ready to meet the challenge of fatty liver disease?","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100234"}}